4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine

C71H73FN20O4S — CID 157181491

IUPAC4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine
SMILESCc1ccc2nc(-c3nc(-c4ccc(C(=O)N5CCC(N(C)C)CC5)cc4)cnc3N)[nH]c2c1.Nc1ncc(-c2ccc(C(=O)NCCN3CCCC3)c(F)c2)nc1-c1nc2ccccc2[nH]1.Nc1ncc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)nc1-c1nc2ccccc2[nH]1
InChIInChI=1S/C26H29N7O.C24H24FN7O.C21H20N6O2S/c1-16-4-9-20-21(14-16)31-25(30-20)23-24(27)28-15-22(29-23)17-5-7-18(8-6-17)26(34)33-12-10-19(11-13-33)32(2)3;25-17-13-15(7-8-16(17)24(33)27-9-12-32-10-3-4-11-32)20-14-28-22(26)21(29-20)23-30-18-5-1-2-6-19(18)31-23;22-20-19(21-25-16-5-1-2-6-17(16)26-21)24-18(13-23-20)14-7-9-15(10-8-14)30(28,29)27-11-3-4-12-27/h4-9,14-15,19H,10-13H2,1-3H3,(H2,27,28)(H,30,31);1-2,5-8,13-14H,3-4,9-12H2,(H2,26,28)(H,27,33)(H,30,31);1-2,5-10,13H,3-4,11-12H2,(H2,22,23)(H,25,26)
InChIKeyAOPSJGWVWLFDNW-UHFFFAOYSA-N
MW1321.57 g/mol
LogP10.03
Rot. Bonds14

About 4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine

4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine (PubChem CID 157181491) has the molecular formula C71H73FN20O4S and a molecular weight of 1321.57 g/mol. Its IUPAC name is 4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine.

Molecular Properties

Compound Name4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine
PubChem CID157181491
Molecular FormulaC71H73FN20O4S
Molecular Weight1321.57 g/mol
Exact Mass1320.58
IUPAC Name4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine
SMILESCc1ccc2nc(-c3nc(-c4ccc(C(=O)N5CCC(N(C)C)CC5)cc4)cnc3N)[nH]c2c1.Nc1ncc(-c2ccc(C(=O)NCCN3CCCC3)c(F)c2)nc1-c1nc2ccccc2[nH]1.Nc1ncc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)nc1-c1nc2ccccc2[nH]1
InChIInChI=1S/C26H29N7O.C24H24FN7O.C21H20N6O2S/c1-16-4-9-20-21(14-16)31-25(30-20)23-24(27)28-15-22(29-23)17-5-7-18(8-6-17)26(34)33-12-10-19(11-13-33)32(2)3;25-17-13-15(7-8-16(17)24(33)27-9-12-32-10-3-4-11-32)20-14-28-22(26)21(29-20)23-30-18-5-1-2-6-19(18)31-23;22-20-19(21-25-16-5-1-2-6-17(16)26-21)24-18(13-23-20)14-7-9-15(10-8-14)30(28,29)27-11-3-4-12-27/h4-9,14-15,19H,10-13H2,1-3H3,(H2,27,28)(H,30,31);1-2,5-8,13-14H,3-4,9-12H2,(H2,26,28)(H,27,33)(H,30,31);1-2,5-10,13H,3-4,11-12H2,(H2,22,23)(H,25,26)
InChIKeyAOPSJGWVWLFDNW-UHFFFAOYSA-N
XLogP10.03
TPSA334.71 Ų
H-Bond Donors7
H-Bond Acceptors18
Rotatable Bonds14
Heavy Atoms97
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001321.57
LogP ≤ 510.03
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1018

Analyze 4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine?
The IUPAC name of 4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine (CID 157181491) is 4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine.
What is the SMILES notation for 4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine?
The canonical SMILES for 4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine is Cc1ccc2nc(-c3nc(-c4ccc(C(=O)N5CCC(N(C)C)CC5)cc4)cnc3N)[nH]c2c1.Nc1ncc(-c2ccc(C(=O)NCCN3CCCC3)c(F)c2)nc1-c1nc2ccccc2[nH]1.Nc1ncc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)nc1-c1nc2ccccc2[nH]1.
What is the InChIKey of 4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine?
The InChIKey is AOPSJGWVWLFDNW-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H29N7O.C24H24FN7O.C21H20N6O2S/c1-16-4-9-20-21(14-16)31-25(30-20)23-24(27)28-15-22(29-23)17-5-7-18(8-6-17)26(34)33-12-10-19(11-13-33)32(2)3;25-17-13-15(7-8-16(17)24(33)27-9-12-32-10-3-4-11-32)20-14-28-22(26)21(29-20)23-30-18-5-1-2-6-19(18)31-23;22-20-19(21-25-16-5-1-2-6-17(16)26-21)24-18(13-23-20)14-7-9-15(10-8-14)30(28,29)27-11-3-4-12-27/h4-9,14-15,19H,10-13H2,1-3H3,(H2,27,28)(H,30,31);1-2,5-8,13-14H,3-4,9-12H2,(H2,26,28)(H,27,33)(H,30,31);1-2,5-10,13H,3-4,11-12H2,(H2,22,23)(H,25,26).
What are the key properties of 4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine?
4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine has a molecular weight of 1321.57 g/mol, XLogP of 10.03, 14 rotatable bonds, 7 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5-amino-6-(1H-benzimidazol-2-yl)pyrazin-2-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)benzamide;[4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]phenyl]-[4-(dimethylamino)piperidin-1-yl]methanone;3-(1H-benzimidazol-2-yl)-5-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazin-2-amine is sourced from PubChem (CID 157181491), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).